Beyonttra (Acoramidis)

Beyonttra (acoramidis) is a transthyretin stabilizer indicated for the treatment of the cardiomyopathy of wild-type or variant transthyretin-mediated amyloidosis (ATTR-CM) in adults to reduce cardiovascular death and cardiovascular-related hospitalization.

Recommended Dosage:
The recommended dosage of Beyonttra is 712 mg taken orally twice daily, with or without food. Tablets are intended to be swallowed whole and must not be cut, crushed, or chewed. If a dose is missed, patients should take the next scheduled dose at the regular time and should not take two doses together to make up for the missed dose.
Patients are advised to follow their healthcare provider’s instructions carefully to ensure safe and effective treatment.

• Patients receiving treatment with Beyonttra (acoramidis) should undergo regular monitoring by their clinician, as worsening heart-related symptoms such as swelling, shortness of breath, or fatigue may still occur despite ongoing treatment for transthyretin amyloid cardiomyopathy.
• Let your doctor know about all medicines, supplements, or herbal products before starting this treatment, because certain medicines may interact with treatment and could affect how the treatment works or increase the risk of undesired side effects.
• The safety of this therapeutic drug during pregnancy or breastfeeding has not been fully established. Women who are pregnant, looking for pregnancy, or breastfeeding should discuss all the risks and benefits with their treating clinician before treatment.
• Patients with severe liver or kidney impairment should use Beyonttra cautiously, as limited clinical evidence is available in these groups. Dose adjustments or additional monitoring may be required depending on the patient’s overall medical condition.
• Although this therapeutic drug is generally well tolerated, some patients may experience mild side effects such as diarrhea, stomach discomfort, or dizziness. Persistent or worsening symptoms should be reported to a doctor for further medical evaluation.

What documents are required to import Beyonttra to India?

Beyonttra (acoramidis) tablets may be imported by patients or government hospitals in the patients’ names only.
The following documentation is required to import the product:

• A valid prescription from a qualified doctor.
• Patient’s diagnostic reports
• Patient ID proof (issued by the Government of India)

How does the order get confirmed?

The order will be confirmed only after the receipt and verification of:

• A valid prescription from the Doctor
• Import permit, if applicable

Is Beyonttra available in India?

Beyonttra (acoramidis tablets) is a (prescription drug, prescription medication, or prescription medicine) pharmaceutical drug that legally requires a medical prescription to be dispensed. As of current publicly available information, Beyonttra is not commercially marketed in India.

IPN (Indian Pharma Network) facilitates the import of cancer medicines under named patient supply (NPS). Indian Pharma Network is the facilitator, providing input

• On the availability of Beyonttra in India (Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Pune, etc.)
• On availability in Gulf countries (Bahrain, Oman, Qatar, Kuwait, Iraq, Saudi Arabia, and the UAE).
  Beyonttra price in India.
• Finding Genuine and reliable sources from the USA, Canada, Europe, and Australia
• Ensuring 100% transparency.

Beyonttra can be made available to patients, doctors, and hospitals in Gurgaon, Delhi, Bangalore, Mumbai, Navi Mumbai, Thane, Hyderabad, Mysore, Kerala, Chennai, Coimbatore, Madurai, Kolkata, Ahmedabad, Surat, Vadodara, Pune, Nagpur, Nashik, Jaipur, Udaipur, Lucknow, Kanpur, Chandigarh, Mohali, Faridabad, Noida, Ghaziabad, Kochi, Trivandrum, Kozhikode, Thrissur, Kannur, Mangalore, Bhubaneswar, Patna, Ranchi, Raipur, Guwahati, Visakhapatnam, Vijayawada, Goa, Jammu, Srinagar, Dehradun, Bhopal, Indore, Ludhiana, Amritsar, and other cities across India. The order will be confirmed only after the receipt of a valid prescription from the doctor and an import permit.

IPN (Indian Pharma Network) can facilitate the supply of Beyonttra (prescription medicines) to all locations in the world and India after fulfilling the legal requirements (if applicable).

Please contact us at WhatsApp: +91 98104 69557 | Toll-Free Number: 1800-1200-365 or write us at info@indianpharmanetwork.in for Beyonttra cost in India.

We guarantee quality and delivery anywhere in the world as per the buyer’s requirements.

Indian Pharma Network can source Beyonttra (Cancer Treatment Medicines) from across the globe and can supply. Indian Pharma offers its customers worldwide access to the best available treatment.

Indian Pharma Network (IPN) can dispense any valid prescription in the shortest possible time. All prescriptions are dispensed and checked by registered pharmacists and dispatched to the Patient’s address only from New Delhi, India.

What is the Generic Name for the trade name drug Beyonttra®?

Acoramidis is the generic name for the trade name drug Beyonttra®.

What is the Manufacturer’s Name of Beyonttra®?

Beyonttra® is manufactured by BridgeBio Pharma, Inc.

Is Beyonttra® approved by the FDA?

No. In the United States, acoramidis is approved under the brand name Attruby®, not Beyonttra®.

Is Beyonttra® approved in the European Union?

Yes, Beyonttra® has been approved in the European Union (EU). The approval was granted by the European Commission in 2025 after evaluating clinical efficacy and safety data.

What strengths and dosage forms are available for Beyonttra®?

Beyonttra® is available as Tablets: 356 mg acoramidis for oral administration.

What are the most common side effects of Beyonttra® Tablets?

The most commonly reported side effects of Beyonttra are stomach-area (abdominal) pain and diarrhea.

How does Beyonttra Import in India work?

Beyonttra Import in India can be done through the Named Patient Program (NPP). This means the medicine can be imported on behalf of the patient with a valid doctor’s prescription. Indian Pharma Network (IPN) helps manage the complete process, including approvals and delivery, making sure the medicine reaches the patient safely and legally.

Who is a reliable Beyonttra supplier in India?

Indian Pharma Network (IPN) is a trusted Beyonttra supplier in India, facilitating compliant access through global sourcing channels and structured documentation support for eligible patients under applicable regulatory provisions.

How much does Beyonttra® Tablet cost in India?

Beyonttra® is not yet approved in India. However, patients in India can legally access it through the provision called the Named Patient Program (NPP). Beyonttra prices may fluctuate over time because of market dynamics and regulatory changes. For the most transparent and latest Beyonttra cost in India, please call/WhatsApp +91 98104 69557 or send an email to info@indianpharmanetwork.in.

Can I buy Beyonttra at major hospitals like AIIMS, Apollo, Sir Ganga Ram, or Fortis?

Beyonttra can be accessed at leading hospitals such as AIIMS Delhi, Sir Ganga Ram Hospital, Medanta – The Medicity, Apollo Hospitals Chennai, Christian Medical College (CMC), PGIMER, Kidwai Memorial Institute of Oncology, Adyar Cancer Institute, Amrita Hospital, Artemis Hospital, Safdarjung Hospital, Kauvery Hospital, Sri Ramachandra Medical Centre, Cytecare Cancer Hospital, MIOT International, SCTIMST, NIMS Hospital, KIMS Hospitals, AIG Hospitals, Bombay Hospital, Lilavati Hospital, Care Hospitals, Narayana Health City, Jaslok Hospital, Yashoda Hospitals, Fortis Memorial Research Institute, Kokilaben Dhirubhai Ambani Hospital, P. D. Hinduja Hospital, Manipal Hospitals, Aster Medcity, Indraprastha Apollo Hospital, King George’s Medical University (KGMU), Shalby Hospitals, Tata Memorial Centre, HCG Cancer Center, Basavatarakam Indo-American Cancer Hospital, Cancer Institute (WIA), Max Healthcare, and Rajiv Gandhi Cancer Institute & Research Centre through the Named Patient Program (NPP) with a valid doctor’s prescription. Indian Pharma Network assists with import and delivery to the treating hospital.

Can Beyonttra® Tablets be available in SAARC countries?

Apart from Gulf countries, Beyonttra® Tablets can be accessed through import provisions like the Named Patient Program (NPP) in SAARC countries (India, Afghanistan, Maldives, Nepal, Bangladesh, Bhutan, Pakistan, and Sri Lanka). Indian Pharma Network (IPN) can help facilitate the legal supply of Beyonttra® Tablets in these countries. We help provide legal access to this therapeutic drug through our reliable channels.

Is it safe to buy Beyonttra® Tablets online in India?

Yes, one can buy Beyonttra in India at the lowest price from the Indian Pharma Network (IPN) if this medicinal product is not yet registered or available in their country. We can help facilitate the import of Beyonttra® Tablets through legal channels.

Who is an authorized Beyonttra importer in India?

Indian Pharma Network (IPN) acts as a Beyonttra importer in India. We help with Named Patient Import processes, regulatory documentation, and compliant procurement from leading international manufacturers for patients who need this therapy.

Where can Beyonttra be shipped in India?

We can assist patients and healthcare providers in accessing Beyonttra across major cities and states in India through the Named Patient Program (NPP).

We can ship Beyonttra in Ahmedabad, Amritsar, Aurangabad, Bangalore, Bhopal, Bhubaneswar, Chandigarh, Chennai, Coimbatore, Dehradun, Delhi, Faridabad, Ghaziabad, Goa, Gurgaon, Guwahati, Hyderabad, Indore, Jaipur, Jammu Kashmir, Kanpur, Kochi, Kolkata, Lucknow, Ludhiana, Madurai, Mangalore, Mumbai, Mysore, Nagpur, Nashik, Navi Mumbai, Noida, Patna, Pune, Raipur, Ranchi, Surat, Thane, Trivandrum, Vadodara, Varanasi, Vijayawada, Visakhapatnam, and other cities across India.

What are the storage conditions of Beyonttra® Tablets?

Store this medicine at controlled room temperature 20°C to 25°C (68°F to 77°F); excursions permitted to 15°C to 30°C (59°F to 86°F). Store in original blister card until use to protect from moisture.

Disclaimer: Beyonttra® (acoramidis tablets) is a prescription medicine and should only be used under the supervision of a qualified healthcare professional. Product availability, import requirements, and access pathways may vary depending on country-specific regulations.